Galapagos NV
GLPG
#4563
Rank
HK$16.44 B
Marketcap
HK$245.92
Share price
-0.57%
Change (1 day)
17.12%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: HK$16.44 Billion

As of December 2025 Galapagos NV has a market cap of HK$16.44 Billion. This makes Galapagos NV the world's 4563th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$16.44 B17.73%
2024HK$13.96 B-33.24%
2023HK$20.92 B-8.36%
2022HK$22.82 B-19.86%
2021HK$28.48 B-43.25%
2020HK$50.19 B-52.29%
2019HK$105.21 B167.69%
2018HK$39.30 B4.75%
2017HK$37.52 B62.38%
2016HK$23.10 B20.95%
2015HK$19.10 B331.6%
2014HK$4.42 B-8.92%
2013HK$4.86 B10.95%
2012HK$4.38 B58.12%
2011HK$2.77 B-16.32%
2010HK$3.31 B67.51%
2009HK$1.97 B148.88%
2008HK$0.79 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Galapagos NV was reported to be:

HK$16.20 Billion
by Nasdaq info icon info icon
HK$16.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
HK$2.176 T 13,138.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$3.787 T 22,934.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$941.14 B 5,624.04%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$3.110 T 18,817.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
HK$0.68 B-95.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.694 T 10,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$254.18 B 1,445.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$760.69 B 4,526.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$1.938 T 11,692.81%๐Ÿ‡บ๐Ÿ‡ธ USA